NR1D1 and type 2 diabetes mellitus: Although the specificity of this compound for REV-ERBα activation is supported by loss-of-function studies in REV-ERBα-deficient mice [23, 25], future work will be important in confirming the specificity of REV-ERBα activation in the modulation of β-cell failure in T2DM.